By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Exalenz Bioscience  

4 Ha` Maayan St

Modiin    71700  Israel
Phone: 972-8-9737500 Fax: 972-8-9737501



Company News
Exalenz Bioscience Announces Collaboration With ALF Study Group To Use BreathID To Monitor Patients With Acute Liver Failure 3/14/2016 6:15:32 AM
Exalenz Bioscience Announces Collaboration With Galectin Therapeutics To Use BreathID To Monitor Patients With Cirrhosis Associated With NASH 8/3/2015 6:24:23 AM
Exalenz Bioscience Launches Clinical Study For Breath-Based Detection Of Primary Liver Cancer (HCC) 6/4/2015 6:28:31 AM
Exalenz Bioscience Launches Additional Clinical Study Of Breath-Based Diagnostic Test Addressing The $2 Billion NASH Market Potential 5/6/2015 6:32:47 AM
Exalenz Bioscience Announces New Published Data Confirming The Clinical Utility Of Its Breathid Test For Detecting H. Pylori In An Emergency Department Setting 4/13/2015 6:22:40 AM
Exalenz Bioscience Launches Pivotal Study Of World’s First Breath-Based Test To Diagnose Clinically Significant Portal Hypertension 10/21/2014 10:58:34 AM
Exalenz Bioscience To Present At Upcoming Investor Conferences 9/29/2014 11:47:14 AM
Deloitte Names Exalenz Bioscience As One Of Israel's Companies-To-Watch In The 2014 Deloitte Technology Fast 50™ Awards 9/23/2014 11:55:39 AM
Exalenz Bioscience Expands Its Breath Testing Technology Into The Potential Billion Dollar Liver Diagnostic Market 5/21/2014 9:00:25 AM
Exalenz Bioscience Granted US Patent for Liver Application of Company’s BreathID Platform Technology 8/21/2013 9:25:22 AM